Interim Medical & Scientific Affairs Lead (Final Signatory)
Location: UK/Remote
Start: June/July 2025
Focus: Rare Disease | Ophthalmology
An exciting opportunity for an experienced ABPI Final Signatory to lead the Medical & Scientific Affairs function for the UK launch of a first-in-class orphan-designated therapy in ophthalmology.
This is a strategic interim role supporting early access, governance, and scientific engagement ahead of a landmark UK launch in 2026.
Key Points:
Interim contract — 2–3 days per week (flexible) ABPI Final Signatory certification (essential) Strong Medical Affairs leadership experience Rare disease or orphan drug exposure is a plus Compassionate Use or Named Patient Programme experience (nice to have) Ophthalmology background (nice to have) Fully remote with occasional travel
Thsi is a start up situation, so you will be shaping the medical governance framework, driving scientific strategy, and partnering cross-functionally to ensure a successful pre-launch phase within a lean, agile setup.
Contract: Approximately 6–9 months, through to post-launch readiness.
If you are interested, please get in touch to arrange a confidential discussion.
#MedicalAffairs #InterimRole #ABPIFinalSignatory #RareDiseases #OrphanDrugs #Ophthalmology #EarlyAccess #HealthcareLeadership #MedicalStrategy #PharmaceuticalIndustry #LifeSciencesJobs #MedicalDirector #ContractRoles #BiotechJobs #LaunchExcellence #HTA #NICE #ClinicalDevelopment #PatientAccess #Compassionate Use
#J-18808-Ljbffr